ATHERSYS, INC / NEW - FORM 10-K - EX-21 - EXHIBIT 21 - March 25, 2011

Attached files

file filename
10-K - FORM 10-K - ATHERSYS, INC / NEWc13875e10vk.htm
EX-23 - EXHIBIT 23 - ATHERSYS, INC / NEWc13875exv23.htm
EX-31.2 - EXHIBIT 31.2 - ATHERSYS, INC / NEWc13875exv31w2.htm
EX-32.1 - EXHIBIT 32.1 - ATHERSYS, INC / NEWc13875exv32w1.htm
EX-31.1 - EXHIBIT 31.1 - ATHERSYS, INC / NEWc13875exv31w1.htm
EX-24.1 - EXHIBIT 24.1 - ATHERSYS, INC / NEWc13875exv24w1.htm
EX-10.48 - EXHIBIT 10.48 - ATHERSYS, INC / NEWc13875exv10w48.htm
EX-10.47 - EXHIBIT 10.47 - ATHERSYS, INC / NEWc13875exv10w47.htm
EX-10.41 - EXHIBIT 10.41 - ATHERSYS, INC / NEWc13875exv10w41.htm
EXHIBIT 21
SUBSIDIARIES OF ATHERSYS, INC.
     
Name of Subsidiary   Jurisdiction
 
ABT Holding Company (formerly Athersys, Inc.)
   Delaware
Advanced Biotherapeutics, Inc.
   Delaware
Athersys Limited
   United Kingdom
ReGenesys LLC
   Delaware
ReGenesys BVBA
   Belgium
Oculus Pharmaceuticals, Inc. (50% ownership)
   Delaware

 

 

ATHERSYS, INC / NEW Reports